United States Erythropoietin Drug Industry 2016 Deep Market Research Report
- QYR605635
- 132 Pages
- June 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Erythropoietin Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Erythropoietin Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 146 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Erythropoietin Drug
1.1.1 Definition of Erythropoietin Drug
1.1.2 Specifications of Erythropoietin Drug
1.2 Classification of Erythropoietin Drug
1.2.1 Epoetin-alfa
1.2.2 Epoetin-beta
1.2.3 Darbepoetin-alfa
1.3 Applications of Erythropoietin Drug
1.4 Industry Chain Structure of Erythropoietin Drug
1.5 Industry Overview of Erythropoietin Drug
1.6 Industry Policy Analysis of Erythropoietin Drug
1.7 Industry News Analysis of Erythropoietin Drug
2 Manufacturing Cost Structure Analysis of Erythropoietin Drug
2.1 Bill of Materials (BOM) of Erythropoietin Drug
2.2 BOM Price Analysis of Erythropoietin Drug
2.3 Labor Cost Analysis of Erythropoietin Drug
2.4 Depreciation Cost Analysis of Erythropoietin Drug
2.5 Manufacturing Cost Structure Analysis of Erythropoietin Drug
2.6 Manufacturing Process Analysis of Erythropoietin Drug
2.7 United States Price, Cost and Gross of Erythropoietin Drug 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Erythropoietin Drug Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Erythropoietin Drug Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Erythropoietin Drug Key Manufacturers in 2015
4 Production Analysis of Erythropoietin Drug by Regions, Type, and Applications
4.1 United States Production of Erythropoietin Drug by Regions 2011-2016
4.2 United States Production of Erythropoietin Drug by Type 2011-2016
4.3 United States Sales of Erythropoietin Drug by Applications 2011-2016
4.4 Price Analysis of United States Erythropoietin Drug Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Erythropoietin Drug 2011-2016
5 Consumption Volume and Consumption Value Analysis of Erythropoietin Drug by Regions
5.1 United States Consumption Volume of Erythropoietin Drug by Regions 2011-2016
5.2 United States Consumption Value of Erythropoietin Drug by Regions 2011-2016
5.3 United States Consumption Price Analysis of Erythropoietin Drug by Regions 2011-2016
6 Analysis of Erythropoietin Drug Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Erythropoietin Drug 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Erythropoietin Drug 2014-2015
6.3 Sales Overview of Erythropoietin Drug 2011-2016
6.4 Supply, Consumption and Gap of Erythropoietin Drug 2011-2016
6.5 Import, Export and Consumption of Erythropoietin Drug 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Erythropoietin Drug 2011-2016
7 Analysis of Erythropoietin Drug Industry Key Manufacturers
7.1 Amgen Inc.
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Johnson and Johnson
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Roche
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Hospira
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 LG Life Sciences Ltd.
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Biocon
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Intas Pharmaceuticals
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Teva Pharmaceutical Industries Ltd.
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Ranbaxy Laboratories Ltd.
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
7.10 Celltrion, Inc
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.2.1 Type I
7.10.2.2 Type II
7.10.2.3 Type III
7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
7.10.4 Contact Information
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Erythropoietin Drug Product Types
8.5 Market Share Analysis of Different Erythropoietin Drug Price Levels
8.6 Gross Margin Analysis of Different Erythropoietin Drug Applications
9 Marketing Trader or Distributor Analysis of Erythropoietin Drug
9.1 Marketing Channels Status of Erythropoietin Drug
9.2 Traders or Distributors of Erythropoietin Drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Erythropoietin Drug
9.4 United States Import, Export and Trade Analysis of Erythropoietin Drug
10 Development Trend of Erythropoietin Drug Industry 2016-2021
10.1 Capacity and Production Overview of Erythropoietin Drug 2016-2021
10.2 Production Market Share by Product Types of Erythropoietin Drug 2016-2021
10.3 Sales and Sales Revenue Overview of Erythropoietin Drug 2016-2021
10.4 United States Sales of Erythropoietin Drug by Applications 2016-2021
10.5 Import, Export and Consumption of Erythropoietin Drug 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Erythropoietin Drug 2016-2021
11 Industry Chain Suppliers of Erythropoietin Drug with Contact Information
11.1 Major Raw Materials Suppliers of Erythropoietin Drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Erythropoietin Drug with Contact Information
11.3 Major Players of Erythropoietin Drug with Contact Information
11.4 Key Consumers of Erythropoietin Drug with Contact Information
11.5 Supply Chain Relationship Analysis of Erythropoietin Drug
12 New Project Investment Feasibility Analysis of Erythropoietin Drug
12.1 New Project SWOT Analysis of Erythropoietin Drug
12.2 New Project Investment Feasibility Analysis of Erythropoietin Drug
13 Conclusion of the United States Erythropoietin Drug Industry 2016 Market Research Report
Figure Picture of Erythropoietin Drug
Table Product Specifications of Erythropoietin Drug
Table Classification of Erythropoietin Drug
Figure United States Sales Market Share of Erythropoietin Drug by Product Types in 2015
Table Applications of Erythropoietin Drug
Figure United States Sales Market Share of Erythropoietin Drug by Applications in 2015
Figure Industry Chain Structure of Erythropoietin Drug
Table United States Industry Overview of Erythropoietin Drug
Table Industry Policy of Erythropoietin Drug
Table Industry News List of Erythropoietin Drug
Table Bill of Materials (BOM) of Erythropoietin Drug
Table Bill of Materials (BOM) Price of Erythropoietin Drug
Table Labor Cost of Erythropoietin Drug
Table Depreciation Cost of Erythropoietin Drug
Table Manufacturing Cost Structure Analysis of Erythropoietin Drug in 2015
Figure Manufacturing Process Analysis of Erythropoietin Drug
Table United States Price Analysis of Erythropoietin Drug 2011-2016 (USD/Unit)
Table United States Cost Analysis of Erythropoietin Drug 2011-2016 (USD/Unit)
Table United States Gross Analysis of Erythropoietin Drug 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Erythropoietin Drug Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Erythropoietin Drug Manufacturers in 2015
Table R&D Status and Technology Source of United States Erythropoietin Drug Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Erythropoietin Drug Key Manufacturers in 2015
Table United States Production of Erythropoietin Drug by Regions 2011-2016 (Unit)
Table United States Production Market Share of Erythropoietin Drug by Regions 2011-2016
Figure United States Production Market Share of Erythropoietin Drug by Regions in 2014
Figure United States Production Market Share of Erythropoietin Drug by Regions in 2015
Table United States Production of Erythropoietin Drug by Types in 2011-2016 (Unit)
Table United States Production Market Share of Erythropoietin Drug by Type in 2011-2016
Figure United States Production Market Share of Erythropoietin Drug by Type in 2014
Figure United States Production Market Share of Erythropoietin Drug by Type in 2015
Table United States Sales of Erythropoietin Drug by Applications 2011-2016 (Unit)
Table United States Production Market Share of Erythropoietin Drug by Applications 2011-2016
Figure United States Production Market Share of Erythropoietin Drug by Applications in 2014
Figure United States Production Market Share of Erythropoietin Drug by Applications in 2015
Table Price Comparison of United States Erythropoietin Drug Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Erythropoietin Drug 2011-2016
Table United States Consumption Volume of Erythropoietin Drug by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Erythropoietin Drug by Regions 2011-2016
Figure United States Consumption Volume Market Share of Erythropoietin Drug by Regions in 2014
Figure United States Consumption Volume Market Share of Erythropoietin Drug by Regions in 2015
Table United States Consumption Value of Erythropoietin Drug by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Erythropoietin Drug by Regions 2011-2016
Figure United States Consumption Value Market Share of Erythropoietin Drug by Regions in 2014
Figure United States Consumption Value Market Share of Erythropoietin Drug by Regions in 2015
Table Consumption Price of Erythropoietin Drug by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Erythropoietin Drug 2011-2016 (Unit)
Table United States Capacity Market Share of Major Erythropoietin Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Erythropoietin Drug 2011-2016 (Unit)
Table United States Production Market Share of Major Erythropoietin Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Erythropoietin Drug 2011-2016 (Unit)
Table United States Sales Market Share of Major Erythropoietin Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Erythropoietin Drug 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Erythropoietin Drug Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Erythropoietin Drug 2011-2016
Figure United States Capacity Utilization Rate of Erythropoietin Drug 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Erythropoietin Drug 2011-2016
Figure United States Production Market Share of Major Erythropoietin Drug Manufacturers in 2014
Figure United States Production Market Share of Major Erythropoietin Drug Manufacturers in 2015
Figure United States Sales Market Share of Major Erythropoietin Drug Manufacturers in 2014
Figure United States Sales Market Share of Major Erythropoietin Drug Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Erythropoietin Drug 2011-2016
Table United States Supply, Consumption and Gap of Erythropoietin Drug 2011-2016 (Unit)
Table United States Import, Export and Consumption of Erythropoietin Drug 2011-2016 (Unit)
Table Price of United States Erythropoietin Drug Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Erythropoietin Drug Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Erythropoietin Drug 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Erythropoietin Drug 2011-2016
Table Amgen Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of Amgen Inc.
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen Inc. 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of Amgen Inc. 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of Amgen Inc. 2011-2016
Table Amgen Inc. Erythropoietin Drug SWOT Analysis
Table Johnson and Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of Johnson and Johnson
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson and Johnson 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of Johnson and Johnson 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of Johnson and Johnson 2011-2016
Table Johnson and Johnson Erythropoietin Drug SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of Roche
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of Roche 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of Roche 2011-2016
Table Roche Erythropoietin Drug SWOT Analysis
Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of Hospira
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Hospira 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of Hospira 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of Hospira 2011-2016
Table Hospira Erythropoietin Drug SWOT Analysis
Table LG Life Sciences Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of LG Life Sciences Ltd.
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of LG Life Sciences Ltd. 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of LG Life Sciences Ltd. 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of LG Life Sciences Ltd. 2011-2016
Table LG Life Sciences Ltd. Erythropoietin Drug SWOT Analysis
Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of Biocon
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biocon 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of Biocon 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of Biocon 2011-2016
Table Biocon Erythropoietin Drug SWOT Analysis
Table Intas Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of Intas Pharmaceuticals
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Intas Pharmaceuticals 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of Intas Pharmaceuticals 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of Intas Pharmaceuticals 2011-2016
Table Intas Pharmaceuticals Erythropoietin Drug SWOT Analysis
Table Teva Pharmaceutical Industries Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of Teva Pharmaceutical Industries Ltd.
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries Ltd. 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of Teva Pharmaceutical Industries Ltd. 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of Teva Pharmaceutical Industries Ltd. 2011-2016
Table Teva Pharmaceutical Industries Ltd. Erythropoietin Drug SWOT Analysis
Table Ranbaxy Laboratories Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of Ranbaxy Laboratories Ltd.
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ranbaxy Laboratories Ltd. 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of Ranbaxy Laboratories Ltd. 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of Ranbaxy Laboratories Ltd. 2011-2016
Table Ranbaxy Laboratories Ltd. Erythropoietin Drug SWOT Analysis
Table Celltrion, Inc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Erythropoietin Drug Picture and Specifications of Celltrion, Inc
Table Erythropoietin Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Celltrion, Inc 2011-2016
Figure Erythropoietin Drug Capacity (Unit), Production (Unit) and Growth Rate of Celltrion, Inc 2011-2016
Figure Erythropoietin Drug Production (Unit) and United States Market Share of Celltrion, Inc 2011-2016
Table Celltrion, Inc Erythropoietin Drug SWOT Analysis
Table Erythropoietin Drug Price by Regions 2011-2016
Table Erythropoietin Drug Price by Product Types 2011-2016
Table Erythropoietin Drug Price by Companies 2011-2016
Table Erythropoietin Drug Gross Margin by Companies 2011-2016
Table Price Comparison of Erythropoietin Drug by Regions 2011-2016 (USD/Unit)
Table Price of Different Erythropoietin Drug Product Types (USD/Unit)
Table Market Share of Different Erythropoietin Drug Price Level
Table Gross Margin of Different Erythropoietin Drug Applications
Table Marketing Channels Status of Erythropoietin Drug
Table Traders or Distributors of Erythropoietin Drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Erythropoietin Drug (USD/Unit) in 2015
Table United States Import, Export, and Trade of Erythropoietin Drug (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Erythropoietin Drug 2016-2021
Figure United States Capacity Utilization Rate of Erythropoietin Drug 2016-2021
Table United States Erythropoietin Drug Production by Type 2016-2021 (Unit)
Table United States Erythropoietin Drug Production Market Share by Type 2016-2021
Figure United States Production Market Share of Erythropoietin Drug by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Erythropoietin Drug 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Erythropoietin Drug 2016-2021
Figure United States Sales of Erythropoietin Drug by Applications 2016-2021 (Unit)
Table United States Production Market Share of Erythropoietin Drug by Applications 2016-2021
Figure United States Production Market Share of Erythropoietin Drug by Applications in 2021
Table United States Production, Import, Export and Consumption of Erythropoietin Drug 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Erythropoietin Drug 2016-2021
Table Major Raw Materials Suppliers of Erythropoietin Drug with Contact Information
Table Manufacturing Equipment Suppliers of Erythropoietin Drug with Contact Information
Table Major Players of Erythropoietin Drug with Contact Information
Table Key Consumers of Erythropoietin Drug with Contact Information
Table Supply Chain Relationship Analysis of Erythropoietin Drug
Table New Project SWOT Analysis of Erythropoietin Drug
Table New Project Investment Feasibility Analysis of Erythropoietin Drug
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
